Vertical growth phase and positive sentinel node in thin melanoma.
Open Access
- 1 March 2003
- journal article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 36 (3), 347-350
- https://doi.org/10.1590/s0100-879x2003000300009
Abstract
Sentinel node (SN) status is the most important prognostic factor for localized melanoma. Usually, patients with Breslow thickness of less than 1.0 mm are not included in SN protocols. However, the literature presents a rate ranging from 3 to 7% of nodal recurrence in thin melanoma. Ulceration, regression and high mitotic rate have been considered to be indications for an SN biopsy. The metastatic potential of the vertical growth phase is uncertain. To correlate pathological features in thin melanoma with SN metastasis, we reviewed 358 patients submitted to SN biopsy. Seventy-seven patients with lesions of 1 mm or smaller were included in the study group. Histological evaluation of the primary tumor included thickness, Clark level, mitotic rate, ulceration, regression, and growth phase. Lymphoscintigraphy was performed on all patients. Lymphatic mapping and gamma probe detection were both used for SN biopsy. Histological examination of SN consisted of hematoxylin-eosin and immunohistochemical staining. Median follow-up was 37 months. Six patients had micrometastases. Statistical analysis by the Fisher test showed that ulceration (P = 0.019), high mitotic rate (P = 0.008) and vertical growth phase (P = 0.002) were positively correlated with micrometastases. If other studies confirm these results, more melanoma patients must be submitted to SN biopsy.Keywords
This publication has 16 references indexed in Scilit:
- Is intra-operative gamma probe detection really necessary for inguinal sentinel lymph node biopsy?Sao Paulo Medical Journal, 2000
- Incidence of Sentinel Node Metastasis in Patients With Thin Primary Melanoma (#1 mm) With Vertical Growth PhaseAnnals of Surgical Oncology, 2000
- Lessons from Tumor Progression: The Invasive Radial Growth Phase of Melanoma Is Common, Incapable of Metastasis, and IndolentJournal of Investigative Dermatology, 1993
- Further validation of the prognostic model for stage I malignant melanoma based on tumor progressionJournal of Cutaneous Pathology, 1993
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989
- Lethal “Thin” Malignant MelanomaAnnals of Surgery, 1988
- Thin Malignant Melanomas and Recurrence PotentialArchives of Surgery, 1987
- A subset in which Level Is the Major Prognostic IndicatorAnnals of Surgery, 1985
- A study of tumor progression: The precursor lesions of superficial spreading and nodular melanomaHuman Pathology, 1984
- Metastasis and Death in Patients with Thin Melanomas (Less than 0.76 mm)Annals of Surgery, 1983